Home >  Investors Relations >  CryoLife, Inc. Receives ''CE'' Mark For International Distribution Of New BioGlue Delivery System

CryoLife to Present at 18th Annual Needham Healthcare Conference

April 3, 2019 at 8:30 AM EDT

ATLANTA, April 3, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18th Annual Needham Healthcare Conference on Wednesday, April 10, 2019 at the Westin Grand Central hotel in New York.

Cryolife logo. (PRNewsFoto/CryoLife, Inc.) (PRNewsFoto/CRYOLIFE_ INC_) (PRNewsFoto/CRYOLIFE, INC.)

A live webcast of the Company's presentation is scheduled to begin at 10:00 a.m. ET and will feature an overview of the company by Pat Mackin, Chairman, President and Chief Executive Officer.  

The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcast will be available for 90 days on the same website.

About CryoLife, Inc.

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.  CryoLife markets and sells products in more than 100 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com


D. Ashley Lee                                                
Executive Vice President, Chief Financial Officer
and Chief Operating Officer
Phone: 770-419-3355

Gilmartin Group LLC
Greg Chodaczek / Lynn Lewis
Phone:  646-924-1769


Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cryolife-to-present-at-18th-annual-needham-healthcare-conference-300823495.html

SOURCE CryoLife, Inc.